WO2003028698A3 - Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique - Google Patents

Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique Download PDF

Info

Publication number
WO2003028698A3
WO2003028698A3 PCT/EP2002/010743 EP0210743W WO03028698A3 WO 2003028698 A3 WO2003028698 A3 WO 2003028698A3 EP 0210743 W EP0210743 W EP 0210743W WO 03028698 A3 WO03028698 A3 WO 03028698A3
Authority
WO
WIPO (PCT)
Prior art keywords
active substance
pharmaceutical active
producing granulates
granulated material
granulates
Prior art date
Application number
PCT/EP2002/010743
Other languages
German (de)
English (en)
Other versions
WO2003028698A2 (fr
Inventor
Klaus-Juergen Steffens
Rudolf Schroeder
Original Assignee
Klaus-Juergen Steffens
Rudolf Schroeder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klaus-Juergen Steffens, Rudolf Schroeder filed Critical Klaus-Juergen Steffens
Priority to AU2002342755A priority Critical patent/AU2002342755A1/en
Priority to EP02779415A priority patent/EP1429735A2/fr
Publication of WO2003028698A2 publication Critical patent/WO2003028698A2/fr
Publication of WO2003028698A3 publication Critical patent/WO2003028698A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un procédé de production de granules comprenant au moins un principe actif pharmaceutique. Selon ledit procédé, la poudre à mettre sous forme de granules est introduite dans une extrudeuse, réduite à l'état de masse de granulation par adjonction d'un liquide de granulation, ladite masse étant compactée grâce à l'application de forces de cisaillement. Un gaz ou un mélange gazeux peut éventuellement être introduit dans la masse de granulation compactée, afin de conférer de la porosité à la masse de granulation.
PCT/EP2002/010743 2001-09-26 2002-09-25 Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique WO2003028698A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002342755A AU2002342755A1 (en) 2001-09-26 2002-09-25 Method and device for producing granulates that comprise at least one pharmaceutical active substance
EP02779415A EP1429735A2 (fr) 2001-09-26 2002-09-25 Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10147414.8 2001-09-26
DE10147414 2001-09-26

Publications (2)

Publication Number Publication Date
WO2003028698A2 WO2003028698A2 (fr) 2003-04-10
WO2003028698A3 true WO2003028698A3 (fr) 2003-10-23

Family

ID=7700318

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/010743 WO2003028698A2 (fr) 2001-09-26 2002-09-25 Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique

Country Status (3)

Country Link
EP (1) EP1429735A2 (fr)
AU (1) AU2002342755A1 (fr)
WO (1) WO2003028698A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834925B2 (en) 2006-08-25 2014-09-16 Purdue Pharma L.P. Tamper resistant dosage forms
US9161917B2 (en) 2008-05-09 2015-10-20 Grünenthal GmbH Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
US9913814B2 (en) 2014-05-12 2018-03-13 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US11844865B2 (en) 2004-07-01 2023-12-19 Grünenthal GmbH Abuse-proofed oral dosage form

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070098801A1 (en) * 2003-09-10 2007-05-03 Janssen Pharmaceutica N.V. Particles shaped as platelets
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
PE20121067A1 (es) 2009-07-22 2012-09-05 Gruenenthal Chemie Forma de dosificacion de liberacion controlada extruida por fusion en caliente
WO2011009604A1 (fr) 2009-07-22 2011-01-27 Grünenthal GmbH Forme galénique inviolable stabilisée à l’oxydation
WO2012028319A1 (fr) 2010-09-02 2012-03-08 Grünenthal GmbH Forme pharmaceutique inviolable comportant un sel inorganique
CA2808541C (fr) 2010-09-02 2019-01-08 Gruenenthal Gmbh Forme pharmaceutique inviolable comportant un polymere anionique
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
KR20140053158A (ko) 2011-07-29 2014-05-07 그뤼넨탈 게엠베하 즉시 약물 방출을 제공하는 탬퍼-저항성 정제
CA2864949A1 (fr) 2012-02-28 2013-09-06 Grunenthal Gmbh Forme pharmaceutique inviolable comprenant un compose pharmacologiquement actif et un polymere anionique
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2913209A1 (fr) 2013-05-29 2014-12-04 Grunenthal Gmbh Forme dosifiee inviolable a profil de liberation bimodale
EP3003279A1 (fr) 2013-05-29 2016-04-13 Grünenthal GmbH Forme pharmaceutique inviolable contenant une ou plusieurs particules
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
WO2015181059A1 (fr) 2014-05-26 2015-12-03 Grünenthal GmbH Microparticules protégées contre une libération massive dans l'éthanol
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
WO2017042325A1 (fr) 2015-09-10 2017-03-16 Grünenthal GmbH Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus
WO2017185040A1 (fr) * 2016-04-22 2017-10-26 University Of Mississippi Granulation à sec à double vis pour la production de formulations solides
DE102016218135A1 (de) 2016-09-21 2018-03-22 Robert Bosch Gmbh Produktionsmodul zum Herstellen fester Arzneiformen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1629423A1 (de) * 1966-04-02 1971-01-14 Gruenzweig & Hartmann Verfahren zur Herstellung von Kunstharz-Schaumstoffen und Verwendung eines nach diesem Verfahren gefertigten Rohres
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
JPH07184550A (ja) * 1993-12-24 1995-07-25 Lotte Co Ltd 比重低減化チューインガムの製造方法
US5496865A (en) * 1993-12-08 1996-03-05 Brugg Kabel Ag Additive-charged porous carrier material

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1629423A1 (de) * 1966-04-02 1971-01-14 Gruenzweig & Hartmann Verfahren zur Herstellung von Kunstharz-Schaumstoffen und Verwendung eines nach diesem Verfahren gefertigten Rohres
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
US5496865A (en) * 1993-12-08 1996-03-05 Brugg Kabel Ag Additive-charged porous carrier material
JPH07184550A (ja) * 1993-12-24 1995-07-25 Lotte Co Ltd 比重低減化チューインガムの製造方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 1995, no. 10 30 November 1995 (1995-11-30) *
SCHROEDER R ET AL: "A new system for continuous wet granulation", PHARMAZEUTISCHE INDUSTRIE 2002 GERMANY, vol. 64, no. 3, 2002, pages 283 - 288, XP009012069, ISSN: 0031-711X *
See also references of EP1429735A2 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844865B2 (en) 2004-07-01 2023-12-19 Grünenthal GmbH Abuse-proofed oral dosage form
US8834925B2 (en) 2006-08-25 2014-09-16 Purdue Pharma L.P. Tamper resistant dosage forms
US8846086B2 (en) 2006-08-25 2014-09-30 Purdue Pharma L.P. Tamper resistant dosage forms
US8894987B2 (en) 2006-08-25 2014-11-25 William H. McKenna Tamper resistant dosage forms
US8894988B2 (en) 2006-08-25 2014-11-25 Purdue Pharma L.P. Tamper resistant dosage forms
US8911719B2 (en) 2006-08-25 2014-12-16 Purdue Pharma Lp Tamper resistant dosage forms
US9084816B2 (en) 2006-08-25 2015-07-21 Purdue Pharma L.P. Tamper resistant dosage forms
US9095614B2 (en) 2006-08-25 2015-08-04 Purdue Pharma L.P. Tamper resistant dosage forms
US9095615B2 (en) 2006-08-25 2015-08-04 Purdue Pharma L.P. Tamper resistant dosage forms
US9101661B2 (en) 2006-08-25 2015-08-11 Purdue Pharma L.P. Tamper resistant dosage forms
US9161917B2 (en) 2008-05-09 2015-10-20 Grünenthal GmbH Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
US9913814B2 (en) 2014-05-12 2018-03-13 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol

Also Published As

Publication number Publication date
EP1429735A2 (fr) 2004-06-23
AU2002342755A1 (en) 2003-04-14
WO2003028698A2 (fr) 2003-04-10

Similar Documents

Publication Publication Date Title
WO2003028698A3 (fr) Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique
IL152024A0 (en) Pharmaceutical compositions containing thyroid hormone and processes for the manufacture thereof
EP1354581A4 (fr) Substance poreuse et son procede de fabrication
HUP0500832A2 (en) Pharmaceutical pellets comprising tamsulosin and process for making the same
WO2008144634A3 (fr) Remplissage d'unités de fenestration
WO2005011570A3 (fr) Granule de carbonate de calcium
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
WO2000024382A3 (fr) Procede pour produire des matieres solides spheriques, contenant une substance biologiquement active
CA2523807A1 (fr) Procede de fabrication de produits chimiques absorbants et formulations de produits chimiques absorbants
WO2005000237A3 (fr) Granules contenant des substances biologiquement actives
WO2003061630A8 (fr) Procede servant a preparer des comprimes
HUP0301844A3 (en) Method and device for the continuous production of organic mono or polyisocyanates
GB0106469D0 (en) Solid formulation
HK1043474A1 (en) Pigment granules for colouring building materials and a method for producing same
HUP9901350A2 (hu) Dezogesztrelt tartalmazó, szárazon granulált, sajtolt tabletták, előállításuk
HK1039684A1 (zh) 規則點陣層狀材料的製備和包含該材料的電子器件製作的低溫處理方法
ID30076A (id) Pulverulen yang berisi serbuk-serbuk karet penggunaan dan proses utnuk pembuatannya
WO1999047543A3 (fr) Composition a liberation prolongee contenant un polymre amorphe
MXPA03004614A (es) Material estabilizado de crepado posterior y metodo para producir el mismo.
MY120081A (en) Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
RU2001129490A (ru) Способ получения гранулированного многокомпонентного удобрения
AU2003272911A8 (en) Granulation system and process for producing powder using granulation system
AU2003284625A8 (en) Granular composition and process for producing the same
HUP9902559A3 (en) Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
WO2005009411A3 (fr) Particules comprenant un principe actif sous forme de co-precipite

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002779415

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002779415

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP